Thermo Fisher Scientific Inc/ US8835561023 /
| 07/11/2024 21:59:56 | Chg. -3.80 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 555.94USD | -0.68% | 49,110 Turnover: 27.38 mill. |
-Bid Size: - | -Ask Size: - | 212.63 bill.USD | 0.25% | 35.82 |
Assets
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 1,408.6000 | 1,656.2000 | 1,726.4000 | 1,767.4000 | 2,426.5000 | ||||||
| Intangible Assets | 6,041.1000 | 7,815.9000 | 7,804.5000 | 7,071.3000 | 14,110.1000 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | - | - | - | 36,312.3000 | ||||||
| Inventories | 1,175.1000 | 1,355.4000 | 1,443.3000 | 1,494.5000 | 1,859.5000 | ||||||
| Accounts Receivable | 1,516.8000 | 1,814.1000 | 1,804.9000 | 1,942.3000 | 2,473.6000 | ||||||
| Cash and Cash Equivalents | 917.1000 | 1,016.3000 | 851 | 5,826 | 1,343.5000 | ||||||
| Current Assets | 4,135 | 4,821.9000 | 4,834.8000 | 9,880.7000 | 6,539.8000 | ||||||
| Total Assets | 21,349.4000 | 26,833.7000 | 27,444.6000 | 31,863.4000 | 42,852.1000 | ||||||
Liabilities
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 551 | 628.7000 | 641.4000 | 691.5000 | 820.7000 | ||||||
| Long-term debt | - | - | - | - | 12,351.6000 | ||||||
| Liabilities to Banks | 105.8000 | 1,272.8000 | 93.1000 | 987.7000 | 2,212.4000 | ||||||
| Provisions | 1,684.4000 | 2,230.9000 | 2,047.2000 | 1,609.9000 | 3,430.7000 | ||||||
| Liabilities | 5,988.4000 | 11,795.6000 | 11,979.9000 | 15,007.3000 | 22,304 | ||||||
| Share Capital | 401.8000 | 406.4000 | 413.5000 | 369.6000 | 408.5000 | ||||||
| Total Equity | 15,361 | 15,038.1000 | 15,464.7000 | 16,856.1000 | 20,548.1000 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 21,349.4000 | 26,833.7000 | 27,444.6000 | 31,863.4000 | 42,852.1000 | ||||||
Income Statement
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 10,788.7000 | 11,725.9000 | 12,509.9000 | 13,090.3000 | 16,889.6000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 1,264.9000 | 1,245.2000 | 1,482.1000 | 1,609.6000 | 2,503 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | 1,164.6000 | 1,126.6000 | 1,269.4000 | 1,319.5000 | 2,087.2000 | ||||||
| Income Taxes | 131.5000 | 107 | 11 | 40.4000 | -191.7000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | - | ||||||
| Net Income | 1,035.6000 | 1,329.9000 | 1,177.9000 | 1,273.3000 | 1,894.4000 | ||||||
Per Share
Cash Flow
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 1,497.8000 | 1,691 | 2,039.5000 | 2,010.7000 | 2,619.6000 | ||||||
| Cash Flow from Investing Activities | -858.9000 | -5,142.2000 | -1,325.8000 | -263.3000 | -11,782.7000 | ||||||
| Cash Flow from Financing | -1,295.1000 | 3,550.6000 | -917.7000 | 3,310 | 4,796.1000 | ||||||
| Decrease / Increase in Cash | -647 | 99.2000 | -165.3000 | 5,020.4000 | -4,482.5000 | ||||||
| Employees | 37,200 | 39,300 | 38,900 | 50,000 | 51,000 | ||||||
